Psychiatry & Neurology, Clinical Neurophysiology · Clermont, FL
NPI
1528226388
Since 2008
Specialty
Psychiatry & Neurology, Clinical Neurophysiology
Code 2084N0600X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
2753 Citrus Tower Blvd
Clermont, FL, 34711
Phone (352) 404-7570
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.7M
317,433 services
Medicare patients, 2024
897
Average age 76
Drug cost, 2024
$4.5M
3,883 prescriptions
Company payments, 2025
$24K
From 40 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Raam Sambandam was code J0174 (injection, lecanemab-irmb, 1 mg), 190,422 times for 18 patients. In total Raam Sambandam billed 317,433 services in 67 codes, and Medicare paid $3.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-05-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0174 Injection, lecanemab-irmb, 1 mg | Office | 190,422 | 18 | $1.05 | $199K |
| J1561 Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | Office | 18,890 | 12 | $38.52 | $728K |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 11,230 | 12 | $34.50 | $387K |
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 7,000 | 12 | $4.97 | $35K |
| 99214 Office E&M - Established | Office | 1,707 | 703 | $98.45 | $168K |
| 96366 Intravenous Infusion, Hydration | Office | 877 | 13 | $16.53 | $14K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 822 | 409 | $13.67 | $11K |
| 96375 Injection Administration | Office | 418 | 15 | $12.44 | $5,201 |
| 96413 Chemotherapy Administration | Office | 290 | 28 | $103.60 | $30K |
| 96365 Intravenous Infusion, Hydration | Office | 266 | 14 | $50.50 | $13K |
| 95886 Electrical Nerve Conductivity | Office | 260 | 122 | $72.00 | $19K |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 257 | 16 | $0.65 | $167 |
| 99205 Office E&M - New | Office | 153 | 153 | $172.51 | $26K |
| 99213 Office E&M - Established | Office | 93 | 40 | $74.12 | $6,893 |
| 95912 Electrical Nerve Conductivity | Office | 91 | 89 | $198.17 | $18K |
By year: 2022 $1.9M for 52,115 services; 2023 $2.0M for 91,240 services; 2024 $3.7M for 317,433 services.
Medicare prescription drug claims, 2024
In 2024, the drug Raam Sambandam prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 289 prescriptions and refills. In total Raam Sambandam wrote 3,883 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 289 | 608 | 111 | $8,177 |
| Gabapentin Generic | 202 | 406 | 83 | $3,810 |
| Memantine Hcl Generic | 182 | 387 | 75 | $4,163 |
| Donepezil Hcl Generic | 169 | 374 | 71 | $1,762 |
| Levetiracetam Generic | 149 | 310 | 48 | $3,411 |
| Pregabalin Generic | 98 | 182 | 43 | $5,120 |
| Duloxetine Hcl Generic | 95 | 200 | 50 | $2,894 |
| Rivastigmine Rivastigmine Tartrate | 90 | 187 | 31 | $4,998 |
| Gammaked Immune Globul G/Gly/Iga Avg 46 | 80 | 80 | Under 11 | $1.0M |
| Amantadine Amantadine Hcl | 77 | 135 | 25 | $5,326 |
| Escitalopram Oxalate Generic | 72 | 134 | 23 | $683 |
| Buspirone Hcl Generic | 71 | 151 | 24 | $1,872 |
| Baclofen Generic | 69 | 121 | 23 | $2,316 |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 68 | 68 | Under 11 | $417K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 65 | 133 | 27 | $2,038 |
Brand drugs: - claims; generic drugs: 3,093 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Raam Sambandam $24K ($24K in general payments such as food, travel and fees) from 40 companies. The largest payer was Lilly USA, LLC with $19K.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 28 | $19K |
| UCB, Inc. UCB.BR | 18 | $514 |
| Pfizer Inc. PFE | 25 | $462 |
| Abbvie Inc. ABBV | 16 | $458 |
| Neurocrine BioSciences, Inc. NBIX | 13 | $344 |
| CSL Behring CSL.AX | 9 | $228 |
| Amneal Pharmaceuticals LLC AMRX | 11 | $226 |
| TG Therapeutics, Inc. TGTX | 8 | $199 |
| Supernus Pharmaceuticals, Inc. SUPN | 12 | $188 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 9 | $179 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.